Emanuela Milani-Tschudy

Vice President, Technology DISCO Pharmaceuticals

Emanuela Tschudy-Milani is Vice President of Technology and Head of DISCO Pharmaceuticals Zürich, where she leads technology development and oversees all operations at the Swiss site. Prior to joining DISCO, she directed the Proteotyping Node within the Tumor Profiler consortium, pioneering multi-omics strategies for personalized oncology. Emanuela has also served as a research scientist and lecturer at ETH Zürich. She holds a PhD in Biochemistry from the Friedrich Miescher Institute in Basel and completed her postdoctoral training at ETH Zürich.

Seminars

Wednesday 4th February 2026
Protein Nanoscale Organization: Unlocking Surfaceomes to Power Next-Generation Therapeutics
2:00 pm
  • Introducing DISCOtech: DISCO's proprietary surfaceome proteomics platform and workflow to systematically map nanoscale organizations on the cell-surface proteins across tumor types
  • Demonstrating how DISCOtech reveals tumor-specific vulnerabilities inaccessible through traditional genomics or transcriptomics
  • Showcasing the translation from surfaceome discoveries to target candidates into differentiated antibody-based therapeutics with enhanced efficacy and safety profiles
Emanuela Milani-Tschudy